Persistence, Dose Titration, and Health Care Resource Utilization Among Crohn ’s Disease Patients Treated With Ustekinumab: A Real-World Analysis in the United States

ConclusionsThe majority of CD patients prescribed UST were biologic experienced, and persistence was high over the 1-year follow-up. UST treatment initiation was associated with reductions in ER visits, inpatient stays, and steroid and other medication use.

Source: Advances in Therapy - March 18, 2020 Category: Drugs & Pharmacology Source Type: research